Moderating the effect of endotoxins

Details Moderating the effect of endotoxins Moderating the effect of endotoxins

A - Human Necessities

61

K

A61K 36/06 (2006.01) A61K 9/00 (2006.01) A61K 35/20 (2006.01) A61K 35/66 (2006.01) A61K 38/01 (2006.01) A61P 1/00 (2006.01) A61P 39/00 (2006.01)

Patent

CA 2542452

The present invention relates to the use of an oral composition comprising yeast extract, in the manufacture of an oral composition to treat the effects of infection by pathogenic bacteria such as Clostridium difficile. Such effects may include the failure of the integrity of the gut epithelial cells and diarrhoea as well as other COX-2 mediated effects.

L'invention concerne l'utilisation d'une composition administrée par voie orale comprenant des extraits de levure, dans la fabrication d'une composition orale permettant de traiter les effets de l'infection entraînées par les bactéries pathogènes telles que les Clostridium difficile. Lesdits effets peuvent comprendre le manque d'intégrité des cellules épithéliales de l'intestin et la diarrhée ainsi que d'autres effets médiés par COX-2.

Affiliated with

Also associated with

Rating

Moderating the effect of endotoxins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Moderating the effect of endotoxins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Moderating the effect of endotoxins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1666296